IL6 and cancer: Importantly, the IL6 trans-signaling pathway is involved in most of the harmful effects of IL-6 in chronic inflammatory diseases and in cancer where it leads to switch on IL6-signaling in tumor or stromal cells expressing zero or low level of IL6R [7].